Monopar Therapeutics - 09 Dec 2024 SCHEDULE 13D/A Report for Gem Pharmaceuticals LLC Common Stock, $0.001 par value (MNPR)

Filing manager: Monopar Therapeutics
Reporting owner: Hendricks Diane
Security: Gem Pharmaceuticals LLC Common Stock, $0.001 par value
Beneficially owned shares: 704,829 shares
Large-stake signal: Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
Ownership
13%
Beneficial ownership of this reported class.
Shares
704,829 shares
Shares beneficially owned as disclosed.
Event date
09 Dec 2024
Date tied to the ownership event or amendment.
Accepted by SEC
07 Feb 2025
EDGAR acceptance date.
How to read this large-stake filing
Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
Compare this filing with the holder history and issuer page before treating the percentage as a current position.
Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Class ownership: 13%
Symbol: MNPR
Shares outstanding: 5,259,918 shares
SEC form: SCHEDULE 13D/A
Accepted by SEC: 07 Feb 2025, 17:01:45 UTC
Event date: 09 Dec 2024
Source filing: View source filing

Key filing fact

Monopar Therapeutics disclosed 13% ownership in Gem Pharmaceuticals LLC Common Stock, $0.001 par value (MNPR) on 09 Dec 2024.

Key facts

Monopar Therapeutics filed SCHEDULE 13D/A for Gem Pharmaceuticals LLC Common Stock, $0.001 par value (MNPR).
Disclosed ownership: 13%.
Date of event: 09 Dec 2024.

This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares owned	Sole voting power	Shared voting power	Signature	Title	CIK
Monopar Therapeutics	12%	611,079	611,079	0	Karl Leo	Managing Member	0001645469
Hendricks Diane	13%	704,829	93,750	611,079	Diane Hendricks	Diane Hendricks	0001727478
Leo Karl	13%	642,391	31,312	611,079	Karl Leo	Karl Leo	0001727480
Pharma Investments LLC	12%	611,079	0	611,079	Diane Hendricks	Managing Member	0001727496

CIK / CUSIP context first

Broader feeds